We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
326
Globus Medical
GMED
$10.6B
$5.32M 0.03%
77,666
-13,126
-14% -$784K
WIT icon
327
Wipro
WIT
$18.9B
$5.31M 0.03%
1,740,000
+528,000
+44% +$1.45M
GPCR icon
328
Structure Therapeutics
GPCR
$3.46B
$5.3M 0.03%
135,000
HALO icon
329
Halozyme
HALO
$9.66B
$5.28M 0.03%
100,813
-80,184
-44% -$3.52M
CHE icon
330
Chemed
CHE
$6.76B
$5.27M 0.03%
+9,721
New +$5.57M
TRV icon
331
Travelers Companies
TRV
$81.4B
$5.27M 0.03%
25,904
+2,705
+12% +$581K
WDAY icon
332
Workday
WDAY
$36.4B
$5.26M 0.03%
23,521
-5,418
-19% -$1.3M
BX icon
333
Blackstone
BX
$106B
$5.23M 0.03%
42,240
+2,217
+6% +$273K
GWW icon
334
W.W. Grainger
GWW
$66B
$5.19M 0.03%
5,749
+642
+13% +$604K
HIG icon
335
Hartford Financial Services
HIG
$38.4B
$5.04M 0.03%
50,109
+8,239
+20% +$827K
RGA icon
336
Reinsurance Group of America
RGA
$15.7B
$4.9M 0.03%
23,855
+1,527
+7% +$305K
EXC icon
337
Exelon
EXC
$48.2B
$4.86M 0.03%
140,560
+22,463
+19% +$829K
CARR icon
338
Carrier Global
CARR
$57.6B
$4.83M 0.03%
76,546
-765
-1% -$47K
PCG icon
339
PG&E
PCG
$47.2B
$4.73M 0.03%
271,081
+35,407
+15% +$623K
CBRE icon
340
CBRE Group
CBRE
$42.1B
$4.72M 0.03%
52,987
+26,687
+101% +$2.37M
JANX icon
341
Janux Therapeutics
JANX
$950M
$4.69M 0.03%
112,004
+31,999
+40% +$1.5M
PEG icon
342
Public Service Enterprise Group
PEG
$39.5B
$4.69M 0.03%
63,611
+6,161
+11% +$438K
RY icon
343
Royal Bank of Canada
RY
$291B
$4.64M 0.03%
43,594
-52,116
-54% -$5.36M
EOG icon
344
EOG Resources
EOG
$74.7B
$4.62M 0.03%
36,739
+4,925
+15% +$632K
WFG icon
345
West Fraser Timber
WFG
$5.18B
$4.6M 0.03%
59,885
RLAY icon
346
Relay Therapeutics
RLAY
$4.06B
$4.59M 0.03%
703,429
+195,000
+38% +$1.33M
FCX icon
347
Freeport-McMoran
FCX
$90.2B
$4.58M 0.03%
94,270
+11,359
+14% +$572K
APH icon
348
Amphenol
APH
$184B
$4.56M 0.03%
67,692
+11,398
+20% +$719K
HRI icon
349
Herc Holdings
HRI
$5.34B
$4.56M 0.03%
+34,184
New +$5.05M
ZS icon
350
Zscaler
ZS
$23.8B
$4.56M 0.03%
23,702
+6,166
+35% +$1.1M

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.